🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Clinical Efficacy of Nobel Parallel CC Implants With on1 Abutment in Posterior Area Participants

RecruitingNAAges 18 Years - 70 YearsAllThe Dental Hospital of Zhejiang University School…
NCT05399589 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

1. Research background NobelBiocare manufacture put forward a new abutment called on1. This concept is based on a two-stage abutment in which the on1 abutment is placed directly on the implant during surgery and will not be disconnected since then. At present, there are very a few clinical prospective studies about clinical effect of Nobelparallel CC implant combined with on1 abutment. 2. Research objective This study will evaluate the clinical efficacy of Nobel parallel with on1 abutment compared to traditional healing cap in posterior teeth in a short term(one year) and long trem (five year) follow-up. 3. Study design and methods: Design type: prospective clinical study. Study duration: 5 years Start time: From the date of adoption of ethics. End time: 2026. Follow up examination: Panoramic images will be taken at all times to measure the marginal bone level of the implant. Clinical e

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
The inclusion criteria were as follows: 1. At least eighteen years old without any medical contraindications, able to tolerate dental implant surgery; 2. Planned to implant with Nobel Parallel CC™ in the maxillary or mandible posterior tooth regions with single-implant-prosthesis design; 3. No requirement for further bone augmentation; 4. Sufficient space to place the abutment and future prosthesis; 5. Adhere to follow-up. The exclusion criteria were as follows: 1. Uncontrolled systematic diseases (blood pressure \>180/100 mmHg, fasting blood glucose \>8.88 mmol/L, myocardial infarction in six months, cardiac function class III to IV, third- or second-degree II atrioventricular block, and double bundle branch block et al.); 2. Using drugs such as bisphosphonates within three months; 3. Heavy smoker (≥ 10 cigarettes per day), alcoholism, and drug abuse; 4. Uncontrolled periodontitis; 5. Implant site infection; 6. Pregnancy or lactation; 7. Severe malocclusion.
💊

What it tests

  • use on1 abutment instead of healing cap in test group
  • use healing cap in control group
📍

Where

1 site
The Affiliated Stomatology Hospital, Zhejiang University School of Medicine, 166 North Qiu'tao Road
Hangzhou, China
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy